🗓️In May 2025, the National Institutes of Health (NIH) announced a new funding opportunity for the Rare Diseases Clinical Research Consortia (RDCRC), emphasizing collaborative, multi-site, and patient-centric non-interventional research. Read the news link below🔗

🌟 This initiative is a major step forward in rare disease research, focusing on:
🤝 Collaboration across institutions and disciplines
🏥 Multi-site studies to reach more patients
🧑‍🤝‍🧑 Patient-centric approaches that put individuals and families first
🔬 Non-interventional (observational) research for deeper insights

📊 Each consortium is required to conduct at least one longitudinal non-interventional (observational) study, with additional projects such as:
📖 Natural history studies
🧪 Biomarker discovery and validation

🎯 The goal: Build robust, regulatory-ready evidence bases to accelerate diagnosis, management, and trial readiness for rare diseases—bringing hope and progress to patients.

👍Clinakos Inc., we support every effort and opportunity to accelerate rare disease innovation through our comprehensive, robust, multi-modal, high-fidelity, patient-centric data curated across multiple sources and sites.

Every rare disease patient deserves a better, faster diagnosis with answers, care, and hope💙

👉Reach out to us to learn more at https://lnkd.in/gp3gUmXc
👉Follow us at Clinakos Inc.

Article Link: https://lnkd.in/gDwWKj88